Takeda announces handful of pipeline cuts in effort to ‘pivot resources’news2025-05-08T20:14:35+00:00May 8th, 2025|Endpoints News|
Illumina forecasts $85M in tariff costs, decrease in China salesnews2025-05-08T20:05:58+00:00May 8th, 2025|Endpoints News|
AstraZeneca loses appeals court fight over IRA drug price negotiationsnews2025-05-08T18:18:36+00:00May 8th, 2025|Endpoints News|
GSK awaits Nucala decision after FDA target date passesnews2025-05-08T17:39:28+00:00May 8th, 2025|Endpoints News|
Verastem wins first FDA approval for ovarian cancer therapynews2025-05-08T17:32:39+00:00May 8th, 2025|Endpoints News|
FDA will convene vaccine advisors to discuss Covid strain updatesnews2025-05-07T19:42:39+00:00May 7th, 2025|Endpoints News|
Gilead reveals plans to put another $11B into US manufacturingnews2025-05-07T19:38:02+00:00May 7th, 2025|Endpoints News|
Teva plans staff cuts as it commits to accelerating growthnews2025-05-07T19:30:41+00:00May 7th, 2025|Endpoints News|
PhRMA warns against tariffs as industry probe closes for commentsnews2025-05-07T18:47:57+00:00May 7th, 2025|Endpoints News|
FDA adcomm to review drugs for four different cancers this monthnews2025-05-07T18:47:10+00:00May 7th, 2025|Endpoints News|
